What is the appropriate management for a group A streptococcus‑positive patient presenting with cheek swelling?

Management of Strep-Positive Patient with Cheek Swelling

A strep-positive patient presenting with cheek swelling requires immediate evaluation for invasive Group A Streptococcus (iGAS) infection, particularly necrotizing fasciitis or deep space infection, which demands urgent surgical consultation, broad-spectrum antibiotics including clindamycin, and intensive monitoring—this is a medical emergency distinct from uncomplicated pharyngitis.

Critical Red Flags Requiring Immediate Action

• Cheek swelling in a strep-positive patient is NOT typical of uncomplicated pharyngitis and raises concern for invasive infection, including necrotizing fasciitis, deep space abscess, or streptococcal toxic shock syndrome 1, 2.
• Necrotizing fasciitis caused by Group A Streptococcus has a case-fatality rate of approximately 20% and requires recognition within hours, not days 3, 2.
• Recent European data show a significant post-COVID increase in invasive GAS infections, with all four recent head and neck necrotizing fasciitis cases presenting with severe pain and facial swelling 1.

Immediate Assessment (Within 1–2 Hours)

Clinical Features Suggesting Invasive Disease

• Severe pain disproportionate to physical findings is the hallmark of necrotizing fasciitis 1, 2.
• Fever (present in 50% of necrotizing fasciitis cases), erythema, induration, or skin changes beyond simple pharyngeal findings 1.
• Systemic toxicity: tachycardia, hypotension, altered mental status, or signs of shock suggest streptococcal toxic shock syndrome 4.
• Rapid progression of swelling or pain over hours 2.

Laboratory Evaluation

• Obtain blood cultures immediately before starting antibiotics 4.
• Complete blood count, comprehensive metabolic panel, creatinine kinase, and lactate to assess for organ dysfunction 4.
• Imaging (CT with contrast) is essential to evaluate for deep space infection, fascial plane involvement, or gas formation 1.

Antibiotic Management

For Suspected or Confirmed Invasive GAS Infection

• Add clindamycin 600–900 mg IV every 8 hours to the antibiotic regimen immediately when necrotizing fasciitis or deep infection is suspected 3.
• Clindamycin is critical because it suppresses toxin production and is more effective than penicillin alone in deep tissue infections 3.
• Combine with penicillin G 4 million units IV every 4 hours (or ampicillin-sulbactam 3 g IV every 6 hours for broader coverage pending culture) 3, 5.
• Broad-spectrum empiric coverage should include coverage for staphylococcus and other pathogens until cultures confirm GAS 5.

For Uncomplicated Pharyngitis (If Invasive Disease Is Ruled Out)

• If imaging and clinical assessment exclude invasive infection, treat as standard GAS pharyngitis with penicillin V 500 mg orally twice daily for 10 days or amoxicillin 500 mg twice daily for 10 days 6.
• For penicillin allergy (non-anaphylactic), use cephalexin 500 mg orally twice daily for 10 days 6.
• For anaphylactic penicillin allergy, use clindamycin 300 mg orally three times daily for 10 days 6.

Surgical Consultation

• Immediate surgical consultation is mandatory if necrotizing fasciitis or deep space infection is suspected 3, 2.
• Emergency surgical debridement is the definitive treatment for necrotizing fasciitis and must not be delayed 2.
• Multiple debridement procedures are often required; three of four recent cases needed repeat operations 1.

Adjunctive Therapies for Invasive Disease

• Intravenous immunoglobulin (IVIG) 1–2 g/kg as a single dose should be considered as adjunctive therapy in necrotizing fasciitis or streptococcal toxic shock syndrome 3, 4.
• Hemoperfusion and corticosteroids have been used in case reports of streptococcal toxic shock syndrome with multiorgan dysfunction 4.
• Vasopressor support, mechanical ventilation, and renal replacement therapy may be required for shock and organ failure 4.

Household Contact Management

• Household contacts of patients with invasive GAS should receive antibiotic prophylaxis to prevent secondary invasive infection 7, 8.
• The secondary attack rate among household contacts is 0.219% without prophylaxis, with an incidence rate ratio of 235 during the 30-day risk period 7.
• Antibiotic prophylaxis reduces secondary iGAS risk by 83% (adjusted OR 0.17) 7.
• Offer chemoprophylaxis to close contacts who are aged ≥75 years, pregnant ≥37 weeks, post-partum, neonates, or those with recent/current chickenpox 8.

Common Pitfalls to Avoid

• Do not dismiss cheek swelling as simple pharyngitis; this presentation demands evaluation for invasive disease 1, 2.
• Do not delay surgical consultation while waiting for imaging or laboratory results if clinical suspicion is high 2.
• Do not use penicillin alone for suspected necrotizing fasciitis; clindamycin must be added 3.
• Do not fail to assess household contacts for prophylaxis needs, especially high-risk individuals 7, 8.
• Do not assume diabetic or immunocompromised patients have simple cellulitis; they are at higher risk for invasive streptococcal infection 4.

Disposition

• Admit all patients with suspected invasive GAS infection to intensive care for close monitoring and aggressive management 4.
• Patients with uncomplicated pharyngitis and minimal cheek swelling (after excluding invasive disease) may be managed outpatient with close 24-hour follow-up and strict return precautions 6.